Rite Aid Corp (RAD):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Rite Aid Corp (RAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9921
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Rite Aid Corp (Rite Aid) is a retail drugstore chain. The company sells prescription drugs and other merchandise such as over-the-counter (OTC) medications, personal care items, health and beauty aids, cosmetics, household items, beverages, convenience foods, greeting cards, and seasonal merchandise. Rite Aid services portfolio includes pharmacy-related solutions including fully integrated mail, specialty and compounding pharmacy services. The company’s stores are integrated into a common information system, which enables customers to fill or refill prescriptions in any of its stores throughout the US. It operates through subsidiaries and retail drugstores in the US. The company caters to employers, insurance companies, unions, government employee groups, health plans, medicare plans, and other sponsors of health benefit plans, and individuals. Rite Aid is headquartered in Camp Hill, Pennsylvania, the US.

Rite Aid Corp (RAD) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Rite Aid Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Rite Aid Corp, Medical Devices Deals, 2012 to YTD 2018 10
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Rite Aid Corp, Pharmaceuticals & Healthcare, Deal Details 12
Private Equity 12
TPG Capital Completes Acquisition Of Envision Pharma 12
Partnerships 14
RediClinic Enters into Joint Venture Agreement with MultiCare Health System 14
Debt Offering 15
Rite Aid Raises USD1.8 Billion in Private Placement of 6.125% Notes Due 2023 15
Rite Aid Completes Private Placement Of Notes Due 2021 For US$810 Million 16
Acquisition 17
Envision Pharma Acquires MedTrak 17
Rite Aid Acquires RediClinic, Operator Of Healthcare Clinics 18
Rite Aid Acquires Health Dialog Services From British United Provident Association 19
Envision Pharma Acquires ProScribe 20
Envision Pharma Acquires Laker Software 21
Rite Aid Acquires Kings Pharmacy East 22
Jean Coutu Completes Sale Of Minority Stake In Rite Aid For US$160 Million 23
MedTrak Services Acquires Beyond Rx From Pharmacy First 24
Rite Aid Corp – Key Competitors 25
Rite Aid Corp – Key Employees 26
Rite Aid Corp – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 29
Financial Announcements 29
Jun 27, 2018: Rite Aid Announces Fiscal 2019 First Quarter Financial Results 29
Apr 13, 2018: Rite Aid posts fiscal 2018 Q4 and full year results 31
Jan 04, 2018: Rite Aid reports fiscal 2018 third quarter results 33
Sep 28, 2017: Rite Aid Reports Fiscal 2018 Second Quarter Results 35
Corporate Communications 36
Nov 17, 2017: Rite Aid Announces Senior Management Changes in Category Management 36
Nov 14, 2017: Rob Mullins Named Senior Vice President of Store Operations, Western Division 37
Nov 02, 2017: Rite Aid: Matt Schroeder Named Senior Vice President, Chief Accounting Officer and Treasurer 38
Sep 28, 2017: Kermit Crawford Joins Rite Aid as President and Chief Operating Officer of Rite Aid 39
Jan 23, 2017: Ken Black Named Senior Vice President of Human Resources and Chief Human Resources Officer 40
Product News 41
Jul 20, 2017: Rite Aid Expands Naloxone Dispensing Program to Michigan and South Carolina 41
Feb 15, 2017: Rite Aid Expands Naloxone Dispensing Program in Six Additional States 42
Feb 12, 2018: Flu Shots Available at Rite Aid as Severe Flu Season Continues 43
Other Significant Developments 44
Aug 27, 2018: Flu Shots now available at all Walgreens Pharmacies, Duane Reade Pharmacies, Walgreens-owned Rite Aid Pharmacies and Walgreens Healthcare Clinics 44
May 21, 2018: Rite Aid Makes Free Opioid Disposal Solution Available At More Than 2,500 Pharmacies Nationwide 45
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47

List of Tables
Rite Aid Corp, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Rite Aid Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Rite Aid Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Rite Aid Corp, Medical Devices Deals, 2012 to YTD 2018 10
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
TPG Capital Completes Acquisition Of Envision Pharma 12
RediClinic Enters into Joint Venture Agreement with MultiCare Health System 14
Rite Aid Raises USD1.8 Billion in Private Placement of 6.125% Notes Due 2023 15
Rite Aid Completes Private Placement Of Notes Due 2021 For US$810 Million 16
Envision Pharma Acquires MedTrak 17
Rite Aid Acquires RediClinic, Operator Of Healthcare Clinics 18
Rite Aid Acquires Health Dialog Services From British United Provident Association 19
Envision Pharma Acquires ProScribe 20
Envision Pharma Acquires Laker Software 21
Rite Aid Acquires Kings Pharmacy East 22
Jean Coutu Completes Sale Of Minority Stake In Rite Aid For US$160 Million 23
MedTrak Services Acquires Beyond Rx From Pharmacy First 24
Rite Aid Corp, Key Competitors 25
Rite Aid Corp, Key Employees 26
Rite Aid Corp, Other Locations 27
Rite Aid Corp, Subsidiaries 27

List of Figures
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Rite Aid Corp, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Rite Aid Corp (RAD):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Frasers Property Limited:企業の戦略・SWOT・財務情報
    Frasers Property Limited - Strategy, SWOT and Corporate Finance Report Summary Frasers Property Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Invion Ltd (IVX):企業の財務・戦略的SWOT分析
    Summary Invion Ltd (Invion) is a life sciences company that develops products for the treatment of inflammatory diseases such as chronic inflammatory, airway disease and inflammation caused by autoimmune disease. The company's pipeline products include INV102 nadolol, a beta adrenergic biased ligand …
  • AngioDynamics Inc (ANGO):医療機器:M&Aディール及び事業提携情報
    Summary AngioDynamics Inc (AngioDynamics) is a provider of minimally invasive medical, surgical and diagnostic devices. Its product portfolio encompasses peripheral vascular products, radiofrequency ablation and NanoKnife systems, vascular access products, angiographic products and accessories, prod …
  • Borges International Group SLU:企業の戦略的SWOT分析
    Borges International Group SLU - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Aditya Birla Sun Life Insurance Company Limited:企業の戦略・SWOT・財務分析
    Aditya Birla Sun Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary Aditya Birla Sun Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Sulzer Ltd (SUN):企業の財務・戦略的SWOT分析
    Sulzer Ltd (SUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Medeon Biodesign Inc (6499):医療機器:M&Aディール及び事業提携情報
    Summary Medeon Biodesign Inc (Medeon Biodesign) is a medical device company that develops patient-centered medical device products that address unmet medical needs. The company’s products include cardiovascular devices and equipment, devices for minimally invasive surgeries, laparoscopic device, hig …
  • The Wharf (Holdings) Limited
    The Wharf (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary The Wharf (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Orchard Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Orchard Therapeutics Ltd (Orchard) is an integrated commercial-stage biotechnology company that develops gene therapies for the treatment of serious and life-threatening orphan diseases. Its pipeline products include Strimvelis, an autologous ex vivo gammaretroviral gene therapy for the trea …
  • SoftBank Group Corp. (Formerly SoftBank Corp.):戦略・SWOT・企業財務分析
    SoftBank Group Corp. (Formerly SoftBank Corp.) - Strategy, SWOT and Corporate Finance Report Summary SoftBank Group Corp. (Formerly SoftBank Corp.) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Yuhan Corp (000100):製薬・医療:M&Aディール及び事業提携情報
    Summary Yuhan Corp (Yuhan) researches, develops, manufactures and markets pharmaceutical products. The company offers API's and intermediates for antibiotic, antiviral, antifungal, anti-inflammatory, anti-diabetic, anti-HIV, anti-HCV, beta-lactase inhibitors, PEGlyated compounds and anti-histamines. …
  • TetraLogic Pharmaceuticals (TLOG)-製薬・医療分野:企業M&A・提携分析
    Summary TetraLogic Pharmaceuticals (TetraLogic) is a biopharmaceutical company that research and develops novel small molecule therapeutics in the areas of oncology and infectious diseases. The company’s clinical stage products include birinapant and SHAPE. Its birinapant is a small molecule therape …
  • GenomicTree Inc:企業の製品パイプライン分析2018
    Summary GenomicTree Inc (GenomicTree) is a medical device company that develops and commercializes diagnostic products for the screening and diagnosis of cancer. The company also provides non-invasive cancer molecular diagnostic product. Its products are used in the detection of colorectal, lung and …
  • Recipharm AB (RECI B):医療機器:M&Aディール及び事業提携情報
    Summary Recipharm AB (Recipharm) is a contract development and manufacturing organization (CDMO) that offers manufacturing, and development and technology services. The organization's manufacturing segment provides contract manufacturing of pharmaceuticals such as semi-solids, and oral liquids, soli …
  • China Petrochemical Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary China Petrochemical Corp (Sinopec Corp) is a petroleum and petrochemical company. The company is engaged in the engaged in the exploration and production, pipeline transportation, and sale of petroleum and natural gas. It is also involved in the production, sale, storage and transportation o …
  • The Middleby Corp (MIDD):企業の財務・戦略的SWOT分析
    The Middleby Corp (MIDD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Canon Marketing Japan Inc (8060):企業の財務・戦略的SWOT分析
    Canon Marketing Japan Inc (8060) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • CIMIC Group Ltd (CIM):企業の財務・戦略的SWOT分析
    CIMIC Group Ltd (CIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • RH Petrogas Ltd (T13):石油・ガス:M&Aディール及び事業提携情報
    Summary RH Petrogas Ltd (RH Petrogas) is an oil and gas company that explores, develops and produces oil and gas resources. The company’s properties include FUYU 1 block, Basin and Island PSC, and SK331 PSC. Its FUYU 1 block property is located in south-east of the Fuyu oilfield in the Jilin provinc …
  • Empresas Copec S.A.:企業の戦略・SWOT・財務情報
    Empresas Copec S.A. - Strategy, SWOT and Corporate Finance Report Summary Empresas Copec S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆